Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Trabectedin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 4 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

Doxorubicin 4 Specimen Handling 3 pazopanib 2 brigimadlin 2 Radiotherapy 2 Radiation 2 Ifosfamide 2 Biopsy 2 talimogene laherparepvec 1 silmitasertib 1 selinexor 1 pembrolizumab 1 palbociclib 1 mirdametinib 1 abemaciclib 1 X-Rays 1 Vincristine 1 Trabectedin 1 Temozolomide 1 Surgical Procedures, Operative 1 Quality of Life 1 Proton Therapy 1 Pioglitazone 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Gemcitabine 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡